Skip to main content
Caplight Logo









Elypta

Elypta

Private
SolnaHealthcare & Life Scienceshttps://elypta.com/

Last Round

Grant

May 1, 2025

Total Funding Raised

$30.41M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Elypta is a biotechnology company that develops a metabolism-based liquid biopsy platform for the early detection and monitoring of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

liquid biopsyearly cancer detectionmulti-cancer early detectionMCEDcancer diagnosticsGAGomemetabolic biomarkerscancer recurrence monitoringmolecular diagnosticsMDxmass spectrometryglycosaminoglycan biomarkerspan-cancer testkidney cancer monitoringresearch use onlyRUOdiagnostic kitUHPLC-MS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elypta Comparables

Compare Elypta with similar companies based on industry and business-model similarity.

Elypta comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dxcover
79%
Biomark Diagnostics Inc.
77%
CanSense
73%

Elypta Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2025
Series AJun 20, 2022
SeedDec 1, 2019
GrantFeb 4, 2019

Key People

Founding team and executive leadership

Karl Bergman

CEO

Executive Team

Johan Vikström

Chief Financial Officer

Executive Team

Elypta Investors

Notable investors and investment history

Elypta investors
InvestorRounds
Nina CapitalSeed, Series A
Bonnier CapitalSeries A
HillclimberSeries A
Navigare VenturesSeries A
Norrsken FoundationSeed
IndustrifondenSeries A, Seed
ScietySeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 172% MoM, reaching 3.4K.

  • Apr 1, 2026

    Monthly visitors grew 96% MoM.

Elypta Filings

Explore SEC and related filing metadata, where available.

Elypta filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Elypta's valuation, stock price, and market status.

Is Elypta a public or private company?

Elypta is a private company.

What is the current stock price of Elypta?

Elypta is a private company with no public stock price. No recent secondary market data is available.

How much is Elypta worth (valuation)?

Valuation information for Elypta is not publicly available.

Can I buy Elypta stock?

Elypta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Elypta's last funding round?

Elypta's most recent funding round was Series A on June 20, 2022.

Who are the main investors in Elypta?

Key investors in Elypta include Bonnier Capital.

Will Elypta IPO soon?

No public IPO plans have been announced for Elypta.

How can I track Elypta secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elypta's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSolna
Employee Range22
Year Founded2017
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?